Literature DB >> 9050884

Antigen presentation in retroviral vector-mediated gene transfer in vivo.

E S Song1, V Lee, C D Surh, A Lynn, D Brumm, D J Jolly, J F Warner, S Chada.   

Abstract

We have examined mechanisms involved in gene transfer, protein expression, and antigen presentation after direct administration of retroviral vectors using a variety of antigen systems. We have identified transduced infiltrating cells at the injection site, and the majority of the infiltrating cells were of the monocyte/macrophage lineage. We found that the splenic dendritic cell fraction contained proviral DNA, expressed antigenic proteins, and was able to present antigens efficiently to the immune system. Furthermore, the dendritic cell fractions from retroviral vector-immunized mice were able to prime naive T cells in vitro, and adoptive transfer of in vitro-transduced dendritic cell fractions elicited antigen-specific cytotoxic T lymphocytes. These data suggest a role for dendritic cells in induction of immune responses elicited by retroviral vector-mediated gene transfer.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9050884      PMCID: PMC20022          DOI: 10.1073/pnas.94.5.1943

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens.

Authors:  J Karttunen; S Sanderson; N Shastri
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

2.  IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement.

Authors:  M Sarmiento; A L Glasebrook; F W Fitch
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

Review 3.  Relation between langerhans cells, veiled cells, and interdigitating cells.

Authors:  E C Hoefsmit; A M Duijvestijn; E W Kamperdijk
Journal:  Immunobiology       Date:  1982-04       Impact factor: 3.144

4.  A monoclonal antibody specific for mouse dendritic cells.

Authors:  M C Nussenzweig; R M Steinman; M D Witmer; B Gutchinov
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

5.  F4/80, a monoclonal antibody directed specifically against the mouse macrophage.

Authors:  J M Austyn; S Gordon
Journal:  Eur J Immunol       Date:  1981-10       Impact factor: 5.532

6.  Primary proliferative and cytotoxic T-cell responses to HIV induced in vitro by human dendritic cells.

Authors:  S E Macatonia; S Patterson; S C Knight
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

Review 7.  Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity.

Authors:  D P Dialynas; D B Wilde; P Marrack; A Pierres; K A Wall; W Havran; G Otten; M R Loken; M Pierres; J Kappler
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

8.  Identification of proliferating dendritic cell precursors in mouse blood.

Authors:  K Inaba; R M Steinman; M W Pack; H Aya; M Inaba; T Sudo; S Wolpe; G Schuler
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

9.  Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro.

Authors:  S Nair; F Zhou; R Reddy; L Huang; B T Rouse
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

10.  Two subsets of epithelial cells in the thymic medulla.

Authors:  C D Surh; E K Gao; H Kosaka; D Lo; C Ahn; D B Murphy; L Karlsson; P Peterson; J Sprent
Journal:  J Exp Med       Date:  1992-08-01       Impact factor: 14.307

View more
  10 in total

1.  Loss of transgene following ex vivo gene transfer is associated with a dominant Th2 response: implications for cutaneous gene therapy.

Authors:  Zhenmei Lu; Soosan Ghazizadeh
Journal:  Mol Ther       Date:  2007-03-13       Impact factor: 11.454

2.  Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells.

Authors:  J Gong; D Avigan; D Chen; Z Wu; S Koido; M Kashiwaba; D Kufe
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

3.  Host immune responses in ex vivo approaches to cutaneous gene therapy targeted to keratinocytes.

Authors:  Z Lu; S Ghazizadeh
Journal:  Exp Dermatol       Date:  2005-10       Impact factor: 3.960

4.  Immune-mediated loss of transgene expression in skin: implications for cutaneous gene therapy.

Authors:  Soosan Ghazizadeh; Richard S Kalish; Lorne B Taichman
Journal:  Mol Ther       Date:  2003-03       Impact factor: 11.454

5.  MUC1 expressing tumor growth was retarded after human mucin 1 (MUC1) plasmid DNA immunization.

Authors:  Hye-Youn Son; Hwan-Kyu Jeong; Vasso Apostolopoulos; Chul-Woo Kim
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.298

6.  Induction of Specific CD8 T Cells against Intracellular Bacteria by CD8 T-Cell-Oriented Immunization Approaches.

Authors:  Toshi Nagata; Yukio Koide
Journal:  J Biomed Biotechnol       Date:  2010-05-24

7.  Vaccination of mice with MUC1 cDNA suppresses the development of lung metastases.

Authors:  Mika Kamata; Kaori Denda-Nagai; Nobuyoshi Kubota; Satoshi Aida; Kazuyoshi Takeda; Tatsuro Irimura
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

8.  In vitro antitumor immune response induced by fusion of dendritic cells and colon cancer cells.

Authors:  Feng Xu; Ying-Jiang Ye; Shan Wang
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

9.  Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.

Authors:  W Zhang; S M Lonning; T C McGuire
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

10.  Molecular cancer vaccines: Tumor therapy using antigen-specific immunizations.

Authors:  T Schweighoffer
Journal:  Pathol Oncol Res       Date:  1997-09       Impact factor: 2.874

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.